We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
TELA Bio®, Inc today announced that Checkmate Capital, a strategic investment group based in Los Angeles, California and Beijing, China, has agreed to an initial Series B investment in TELA Bio.